NCCN Clinical Practice Guidelines in Oncology Symposium: Non-Small Cell Lung Cancer – Neoadjuvant Combined Modality Therapy for Potentially Resectable Stage III Non-Small Cell Lung Cancer

Download Podcast

Listen to MP3

Podcast Evaluation

Recorded at a symposium hosted by Roswell Park Cancer Institute on September 17, 2007

Presenter

Mark G. Kris, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

Faculty Disclosure Statement

Dr. Kris has disclosed that he has no financial interests, arrangements, or affiliations with the manufacturer of products and devices to be discussed in his presentation or who may financially support the educational activity. 

Dr. Kris has indicated that his presentation will include discussion of investigational or unlabeled uses of a product.

Program Overview

Based on the deliberations of experts from 21 leading cancer centers, the NCCN Clinical Practice Guidelines in Oncology™ Non-Small Cell Lung Cancer provide sequential recommendations for the management of lung malignancies. This program will present these algorithms and focus on new approaches that have been incorporated into the guidelines, including the use of drugs, biologics, and diagnostics.

Educational Objectives

Following this activity, participants should be able to:

• Summarize the role of adjuvant therapy for locally advanced disease
• Differentiate management of treatment of patients with local disease, locally advanced disease, and metastatic non-small cell lung cancer

Intended Audience

This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer.

Activity Instructions

Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation.  Participants should review the learning objectives and faculty disclosure statements prior to listening to a presentation in its entirety.  You must be connected to the Internet in order to review and complete the evaluation form.  A statement of credit will be electronically generated once you complete the evaluation form.  To receive credit, this activity must be completed no later than November 29, 2008.  There is no fee for participating in this activity.

Download Podcast

Listen to MP3

Podcast Evaluation

Accreditation Information

Physicians

The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NCCN designates this educational activity for a maximum of 0.75 AMA PRA Category 1
Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

This activity is approved for 0.8 contact hours.  National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Release date:  November 29, 2007
Expiration date:  November 29, 2008

Commercial Support

Distribution supported by educational grants from Abraxis BioScience, Inc., Amgen Oncology, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology/OSI Pharmaceuticals, ImClone Systems Incorporated, and sanofi-aventis U.S.